# Biology to Prevention Award

**Funder:** Cancer Research UK
**Budget:** £100k–£600k
**Deadline:** 4 December 2026
**Duration:** Up to 5 years
**Consortium:** Optional — collaborations between cancer prevention researchers and other disciplines strongly encouraged; UK-US (ACS) and UK-Canada (CCS) co-funding partnerships available with joint lead applicants
**Application:** Single stage, but requires mandatory informal eligibility discussion with CRUK before submission on Flexi-Grant
**Frequency:** Biannual
**Eligible countries:** GB
**Official call:** https://www.cancerresearchuk.org/for-researchers/apply-for-and-manage-your-funding/our-funding-schemes/biology-to-prevention-award
**Last updated:** 18 Oct 2026

## Eligibility & scope

Supports translational research on biological mechanisms of cancer prevention; applicant must be postdoctoral-level scientist/clinician based at UK university, medical school, hospital or research institute, mostly fully funded by host institution. Co-funding partnerships available with US (ACS) and Canadian (CCS) teams.

## Summary

The Biology to Prevention Award from Cancer Research UK funds translational research into the biological mechanisms of cancer prevention, with grants of £100k to £600k over up to five years. It is open to postdoctoral researchers based at a UK university, medical school, hospital or research institute, and encourages collaboration with geneticists, immunologists and drug developers, plus optional co-funding partnerships with American Cancer Society or Canadian Cancer Society teams. Applicants must complete a mandatory informal discussion with CRUK before submitting via Flexi-Grant.

## Who should apply

- Postdoctoral researchers with experience beyond PhD level
- Based at a UK university, medical school, hospital or research institute
- Working on biological mechanisms underlying cancer prevention
- Interested in cross-disciplinary collaboration with geneticists, immunologists or drug developers
- Open to international co-funding partnerships with US or Canadian cancer charities

## Key dates

- Deadline: 4 December 2026
- Single-stage application via Flexi-Grant, following mandatory informal discussion with CRUK before submission
- Up to 5-year project duration; call runs biannually

## Tips for applicants

- Book the mandatory informal discussion with CRUK well before the deadline, this is a gating step, not a formality, and can shape the eventual proposal.
- If pursuing co-funding with ACS or CCS, coordinate timelines early since partner-country review adds complexity to a single-stage submission.
- Frame the biological mechanism clearly in terms of its prevention application; CRUK reviewers for this call expect a translational link, not pure mechanistic biology.

## Frequently asked questions

### How much funding does the CRUK Biology to Prevention Award provide?

Awards range from £100k to £600k, covering projects of up to five years.

### Who is eligible for the Biology to Prevention Award?

Postdoctoral researchers based at a UK university, medical school, hospital or research institute, with host institution approval.

### Do I need to talk to CRUK before applying?

Yes, a mandatory informal discussion with CRUK is required before submitting an application via Flexi-Grant.

### Can international collaborators be included in this grant?

Yes, optional co-funding partnerships with American Cancer Society (US) or Canadian Cancer Society (Canada) teams are possible, alongside collaborations with biologists, geneticists, immunologists or drug developers.

### How often does CRUK run this call?

The Biology to Prevention Award call runs biannually.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/cancer-research-uk-biology-to-prevention-award-2026-12) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md&grant=cancer-research-uk-biology-to-prevention-award-2026-12).